Author

J. de la Rubia

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

CD84 Expression Across Disease Stages and Leukemic Subpopulations in Acute Myeloid Leukemia

Simple Summary Acute myeloid leukemia (AML) remains a challenging disease, and new therapeutic targets are needed to improve patient outcomes. CD84 has recently emerged as a promising target for immunotherapeutic approaches, including CAR T-cell therapy. In this study, we evaluated CD84 expression in samples from adult...

B. Martín-Herreros, L. Cordón, R. Rodríguez-Veiga et al. · Cancers · 0 citations

Open access Aug 2026

Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy

Simple Summary Natural killer cells are promising candidates for cellular therapy after allogeneic hematopoietic stem cell transplantation because they can help control malignant cells and viral infections with a low risk of graft-versus-host disease. However, the ability to manufacture these cells consistently under g...

Rut Meseguer, Cristóbal Aguilar, P. Amat et al. · Cancers · 0 citations

Sep 2026

Mutational Landscape and Clonal Dynamics in AML Undergoing PTCy Hematopoietic Cell Transplantation.

To improve risk stratification, we performed targeted NGS at diagnosis in 191 patients with AML undergoing myeloablative allogeneic HCT with PTCy-based prophylaxis. We also investigated clonal evolution using paired diagnostic and relapse samples from 39 individuals. A total of 610 mutations were detected in 184 patien...

M. Villalba, J. V. Gil, J. Montoro et al. · Transplantation and Cellular... · 0 citations